Chargement en cours...
Bedaquiline inhibits the yeast and human mitochondrial ATP synthases
Bedaquiline (BDQ, Sirturo) has been approved to treat multidrug resistant forms of Mycobacterium tuberculosis. Prior studies suggested that BDQ was a selective inhibitor of the ATP synthase from M. tuberculosis. However, Sirturo treatment leads to an increased risk of cardiac arrhythmias and death,...
Enregistré dans:
| Publié dans: | Commun Biol |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group UK
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7438494/ https://ncbi.nlm.nih.gov/pubmed/32814813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-020-01173-z |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|